A detailed history of Daiwa Securities Group Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 8,618 shares of ROIV stock, worth $103,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,618
Previous 8,859 2.72%
Holding current value
$103,416
Previous $94,000 5.32%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$10.17 - $12.5 $2,450 - $3,012
-241 Reduced 2.72%
8,618 $99,000
Q2 2024

Aug 07, 2024

SELL
$10.36 - $11.74 $20,823 - $23,597
-2,010 Reduced 18.49%
8,859 $94,000
Q1 2024

May 02, 2024

SELL
$9.87 - $11.8 $7,580 - $9,062
-768 Reduced 6.6%
10,869 $115,000
Q4 2023

Jan 31, 2024

BUY
$8.38 - $11.58 $335 - $463
40 Added 0.34%
11,637 $131,000
Q2 2023

Jul 31, 2023

SELL
$7.09 - $10.08 $15,434 - $21,944
-2,177 Reduced 15.81%
11,597 $117,000
Q1 2023

May 02, 2023

BUY
$6.92 - $9.98 $14,753 - $21,277
2,132 Added 18.31%
13,774 $102,000
Q4 2022

Feb 06, 2023

BUY
$3.36 - $7.99 $2,842 - $6,759
846 Added 7.84%
11,642 $93,000
Q3 2022

Nov 02, 2022

BUY
$0.51 - $4.84 $5,505 - $52,252
10,796 New
10,796 $35,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.45B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.